These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17499203)

  • 21. Evaluation of the anti-allergic activity of Citrus unshiu using rat basophilic leukemia RBL-2H3 cells as well as basophils of patients with seasonal allergic rhinitis to pollen.
    Kobayashi S; Tanabe S
    Int J Mol Med; 2006 Mar; 17(3):511-5. PubMed ID: 16465400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saikosaponin-d inhibits β-conglycinin induced activation of rat basophilic leukemia-2H3 cells.
    Hao Y; Piao X; Piao X
    Int Immunopharmacol; 2012 Jul; 13(3):257-63. PubMed ID: 22580215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin gallate inhibits histamine release from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway.
    Yamashita K; Suzuki Y; Matsui T; Yoshimaru T; Yamaki M; Suzuki-Karasaki M; Hayakawa S; Shimizu K
    Biochem Biophys Res Commun; 2000 Aug; 274(3):603-8. PubMed ID: 10924324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
    Misawa M; Kanai Y
    Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azelastine and suplatast shorten the distribution half-life of IgE in rats.
    Hanashiro K; Tokeshi Y; Nakasone T; Sunagawa M; Nakamura M; Kosugi T
    Mediators Inflamm; 2002 Feb; 11(1):61-4. PubMed ID: 11926596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and identification of the recombinant hFcεRIα/RBL-2H3 cells.
    Liu Z; Hao L; Wang N; Zhang S; Zhang N; Xu Z; Yang Y; Zhang Y
    Plasmid; 2018 Jun; 98():31-36. PubMed ID: 30213734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
    Péterfy H; Tóth G; Pecht I; Erdei A
    Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.
    Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ
    Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavones suppress the expression of the high-affinity IgE receptor FcepsilonRI in human basophilic KU812 cells.
    Yano S; Tachibana H; Yamada K
    J Agric Food Chem; 2005 Mar; 53(5):1812-7. PubMed ID: 15740078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of phloretin and biochanin A on IgE-mediated allergic responses in rat basophilic leukemia RBL-2H3 cells.
    Chung MJ; Sohng JK; Choi DJ; Park YI
    Life Sci; 2013 Sep; 93(9-11):401-8. PubMed ID: 23907072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
    Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
    Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and identification of serine and threonine phosphorylated proteins in activated mast cells: implications for regulation of protein synthesis in the rat basophilic leukemia mast cell line RBL-2H3.
    Olson FJ; Ludowyke RI; Karlsson NG
    J Proteome Res; 2009 Jun; 8(6):3068-77. PubMed ID: 19317463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of defective phorbol ester responses in a low secreting rat basophilic leukemia (RBL-2H3) cell variant.
    Monk PN; Bingham BR; Ahmad TB; Helm BA
    Receptor; 1993; 3(2):77-86. PubMed ID: 8251953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tanshinones inhibit mast cell degranulation by interfering with IgE receptor-mediated tyrosine phosphorylation of PLCgamma2 and MAPK.
    Choi HS; Kim KM
    Planta Med; 2004 Feb; 70(2):178-80. PubMed ID: 14994199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approaches to the inhibition of mast cells in allergic disease.
    Bradding P
    Clin Exp Allergy; 2008 May; 38(5):704-8. PubMed ID: 18325033
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions.
    Belostotsky R; Lorberboum-Galski H
    Clin Immunol; 2004 Jan; 110(1):89-99. PubMed ID: 14962800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monomeric immunoglobulin E stabilizes FcepsilonRIalpha from the human basophil cell line KU812 by protecting it from natural turnover.
    Jensen BM; Hansen JB; Dissing S; Gerwien J; Skov PS; Poulsen LK
    Clin Exp Allergy; 2003 May; 33(5):655-62. PubMed ID: 12752595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of mast cell signaling through high-affinity IgE receptor by CD45 protein tyrosine phosphatase.
    Murakami K; Sato S; Nagasawa S; Yamashita T
    Int Immunol; 2000 Feb; 12(2):169-76. PubMed ID: 10653852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bifidobacterium suppresses IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells.
    Harata G; He F; Takahashi K; Hosono A; Kawase M; Kubota A; Hiramatsu M; Kaminogawa S
    Microbiol Immunol; 2010; 54(1):54-7. PubMed ID: 20055943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoflavones suppress the expression of the FcεRI high-affinity immunoglobulin E receptor independent of the estrogen receptor.
    Yamashita S; Tsukamoto S; Kumazoe M; Kim YH; Yamada K; Tachibana H
    J Agric Food Chem; 2012 Aug; 60(34):8379-85. PubMed ID: 22871233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.